Carswell G F, Anast C S, Thompson I M, Ross G
Trans Am Assoc Genitourin Surg. 1977;69:113-7.
Our results with radioimmunoassay studies for parathyroid hormone performed during the last 6 years are compared retrospectively to results of the laboratory tests customarily secured when hyperparathyroidism is suspected. The results obtained in patients with known primary hyperparathyroidism and in patients with unconfirmed but presumptive hyperparathyroidism are compared to the results obtained from a group of normal controls. Despite the fact that certain discrepant results were noted in the earlier assay techniques the over-all results and, in particular, those of more recent years have been highly sensitive and reproducible corroboratives of the existence of primary hyperparathyroidism. About two-thirds of the patients with primary hyperparathyroidism will present to the urologist. All patients with calcium-containing stones should have at least 3 determinations of the serum calcium in screening for primary hyperparathyroidism. The radioimmunoassay for parathyroid hormone provides the most reliable confirmation. The patient with calculous disease, elevation of the immunoreactive parathyroid hormone level and hypercalcemia is virtually certain to have primary hyperparathyroidism.
我们对过去6年中进行的甲状旁腺激素放射免疫分析研究结果进行了回顾性比较,与怀疑甲状旁腺功能亢进时常规获得的实验室检查结果进行对比。将已知原发性甲状旁腺功能亢进患者以及未经证实但疑似甲状旁腺功能亢进患者的结果与一组正常对照者的结果进行比较。尽管在早期检测技术中发现了某些不一致的结果,但总体结果,尤其是近年来的结果,对于原发性甲状旁腺功能亢进的存在具有高度敏感性和可重复性的佐证。约三分之二的原发性甲状旁腺功能亢进患者会就诊于泌尿科医生。所有患有含钙结石的患者在筛查原发性甲状旁腺功能亢进时应至少进行3次血清钙测定。甲状旁腺激素放射免疫分析提供了最可靠的确诊依据。患有结石病、免疫反应性甲状旁腺激素水平升高和高钙血症的患者几乎肯定患有原发性甲状旁腺功能亢进。